Diacon, Andreas H.
Barry, Clifton E. III http://orcid.org/0000-0002-2927-270X
Carlton, Alex
Chen, Ray Y.
Davies, Matt http://orcid.org/0000-0001-7545-8460
de Jager, Veronique
Fletcher, Kim
Koh, Gavin C. K. W. http://orcid.org/0000-0002-7336-1566
Kontsevaya, Irina
Heyckendorf, Jan
Lange, Christoph http://orcid.org/0000-0002-9691-4741
Reimann, Maja
Penman, Sophie L.
Scott, Rhona
Maher-Edwards, Gareth
Tiberi, Simon
Vlasakakis, Georgios
Upton, Caryn M. http://orcid.org/0000-0002-7503-3320
Aguirre, David Barros http://orcid.org/0000-0002-4099-0438
Article History
Received: 8 June 2023
Accepted: 22 January 2024
First Online: 16 February 2024
Competing interests
: A.C., R.S., G.M.-E., S.T. and M.D. are employees of, and shareholders in, GSK. D.B.A. is an employee of, and shareholder in, GSK, and reports patents planned, issued or pending. S.L.P., G.V. and K.F. are employees of GSK and hold stocks in GSK and Haleon. G.C.K.W.K. is a shareholder in GSK, reports conference fees, expenses and accommodation support from GSK while an employee, and is currently employed by Generate:Biomedicines, Boston, MA, USA. C.L. is supported by the German Center of Infection Research, has provided consultation service to INSMED, has received honoraria for lecturing from INSMED, GILEAD, GSK, MedUpdate and MedUpdateEurope outside of this work, and is a member of the Data Safety Board of trials from Medicines sans Frontiers. C.M.U. received EDCTP grant funding. J.H. received speaker honoraria from GSK and Chiesi, has received support from Boehringer Ingelheim for attending meetings and/or travel, and reports patents planned, issues or pending. A.H.D., I.K., C.E.B., M.R., R.Y.C. and V.d.J. report no conflict of interest.